Genome-wide association studies in atherothrombosis

Luca Andrea Lotta

Research output: Contribution to journalArticlepeer-review


Atherothrombotic diseases are complex diseases, arising from the interaction between several genetic and environmental factors. Until recently, the genetic basis of complex diseases in general, and of atherothrombosis in particular, were poorly characterized. Progress in DNA analysis techniques and the increasing level of characterization of the variability of the human genome has recently allowed to study comprehensively the association between genetic variants and diseases. To date, more than 400 genome-wide association studies have been conducted, allowing to identify more than 430 genomic regions at which common genetic variants influence the predisposition to complex diseases of great epidemiological relevance. This review article summarizes the progress achieved in the genetic basis of atherothrombotic diseases such as myocardial infarction and ischemic stroke. The advances achieved so far now await for clinical applications.

Original languageEnglish
Pages (from-to)74-78
Number of pages5
JournalEuropean Journal of Internal Medicine
Issue number2
Publication statusPublished - Apr 2010


  • Genome-wide association study atherothrombotic disease
  • Genome-wide association study coronary artery disease
  • Genome-wide association study myocardial infarction
  • Genome-wide association study stroke

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Genome-wide association studies in atherothrombosis'. Together they form a unique fingerprint.

Cite this